The obesity and inflammatory marker haptoglobin attracts monocytes via interaction with chemokine (C-C motif) receptor 2 (CCR2)
Authors:
- Margherita MaffeiMMMargherita Maffei
- Marcella FunicelloMFMarcella Funicello
- Teresa VottariTVTeresa Vottari
- Olimpia GamucciOGOlimpia Gamucci
- Mario CostaMCMario Costa
- Simonetta LisiSLSimonetta Lisi
- Alessandro ViegiAVAlessandro Viegi
- Osele CiampiOCOsele Ciampi
- Giuseppe BardiGBGiuseppe Bardi
- Paolo VittiPVPaolo Vitti
- Aldo PincheraAPAldo Pinchera
- Ferruccio SantiniFSFerruccio Santini
Open Access
- 17 December 2009
- journal article
- research article
- Published by Springer Nature in BMC Biology
- Vol. 7 (1) , 1-14
Abstract
Obesity is a chronic low inflammatory state. In the obesity condition the white adipose tissue (WAT) is massively infiltrated with monocytes/macrophages, and the nature of the signals recruiting these inflammatory cells has yet to be fully elucidated. Haptoglobin (Hp) is an inflammatory marker and its expression is induced in the WAT of obese subjects. In an effort to elucidate the biological significance of Hp presence in the WAT and of its upregulation in obesity we formulated the hypothesis that Hp may serve as a macrophage chemoattractant. We demonstrated by chemotaxis assay that Hp is able to attract chemokine (C-C motif) receptor 2 (CCR2)-transfected pre-B lymphocytes and monocytes in a dose-dependent manner. Moreover, Hp-mediated migration of monocytes is impaired by CCR2-specific inhibition or previous cell exposure to monocyte chemoattractant protein 1 (MCP1) (also known as CCR2 ligand or chemokine (C-C motif) ligand 2 (CCL2)). Downstream effects of Hp/CCR2 interaction were also investigated: flow cytometry proved that monocytes treated with Hp show reduced CCR2 expression on their surface; Hp interaction induces calcium release that is reduced upon pretreatment with CCR2 antagonist; extracellular signal-regulated kinase (ERK)1/2, a signal transducer activated by CCR2, is phosphorylated following Hp treatment and this phosphorylation is reduced when cells are pretreated with a specific CCR2 inhibitor. Consistently, blocking the ERK1/2 pathway with U0126, the selective inhibitor of the ERK upstream mitogen-activated protein (MAP)-ERK kinase (MEK), results in a dramatic reduction (by almost 100%) of the capability of Hp to induce monocyte migration. Our data show that Hp is a novel monocyte chemoattractant and that its chemotactic potential is mediated, at least in part. by its interaction with CCR2.Keywords
This publication has 47 references indexed in Scilit:
- Obesity induces a phenotypic switch in adipose tissue macrophage polarizationJournal of Clinical Investigation, 2007
- Inflammation and insulin resistanceJournal of Clinical Investigation, 2006
- MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesityJournal of Clinical Investigation, 2006
- CCR2 modulates inflammatory and metabolic effects of high-fat feedingJournal of Clinical Investigation, 2006
- Fundamentally different roles for LFA-1, Mac-1 and α4-integrin in neutrophil chemotaxisJournal of Cell Science, 2005
- Regulation of haptoglobin gene expression in 3T3-L1 adipocytes by cytokines, catecholamines, and PPARγBiochemical and Biophysical Research Communications, 2004
- Acute‐phase protein haptoglobin is a cell migration factor involved in arterial restructuringThe FASEB Journal, 2002
- Obesity modulates the expression of haptoglobin in the white adipose tissue via TNFαJournal of Cellular Physiology, 2002
- Haptoglobin Genotype as a Risk Factor for Diabetic RetinopathyJAMA, 2000
- Actions of the chemotactic cytokines MCP‐1, MCP‐2, MCP‐3, RANTES, MIP‐1α and MIP‐1β on human monocytesEuropean Journal of Immunology, 1995